Integrating Public Health Concerns into Patent Legislation in Developing Countries
(2000; 140 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoTHE SOUTH CENTRE
Ver el documentoFOREWORD
Ver el documentoACKNOWLEDGEMENTS
Ver el documentoGLOSSARY*
Abrir esta carpeta y ver su contenidoI. INTRODUCTION
Abrir esta carpeta y ver su contenidoII. PATENTABLE SUBJECT MATTER
Abrir esta carpeta y ver su contenidoIII. SCOPE OF CLAIMS
Abrir esta carpeta y ver su contenidoIV. PATENTABILITY REQUIREMENTS
Abrir esta carpeta y ver su contenidoV. SPECIAL CASES IN PHARMACEUTICALS
Abrir esta carpeta y ver su contenidoVI. DISCLOSURE
Abrir esta carpeta y ver su contenidoVII. EXCEPTIONS TO EXCLUSIVE RIGHTS
Cerrar esta carpetaVIII. EXAMINATION AND OBSERVATION PROCEDURES
Ver el documentoVIII.1 Options - Third Parties Opposition
Abrir esta carpeta y ver su contenidoIX. CLAIMS INTERPRETATION
Abrir esta carpeta y ver su contenidoX. COMPULSORY LICENSING
Ver el documentoXI. FINAL REMARKS
Ver el documentoREFERENCES
Ver el documentoBACK COVER
 

VIII.1 Options - Third Parties Opposition

Possible texts to deal with this issue may include the following options:

Third Parties Opposition
Model Options

1. Any interested person shall have the right to file observations on an application, within ... days from the publication of the application, if such person deems that the invention does not meet any of the patentability requirements or that the application does not comply with other provisions of the law. In examining the application, the Patent Office shall take into consideration the reasons alleged by the third party.

2. After the granting of a patent, any interested person may apply for an order before the Patent Office to revoke the patent on any of the grounds upon which the grant of the patent could have been refused.

Where observations or an application for revocation are made under this section, the Patent Office shall notify the applicant or the patentee, and shall give him an opportunity to be heard before deciding the case.

Option 1 stipulates an ex-ante system of opposition. Under this system, the observations by third parties would be submitted after publication of the application and before granting of the patent. It is important in this case to make it clear that the examiner is obliged to take into consideration the observations made, either to admit or disregard them.

Option 2 provides for the revocation of a granted patent on the basis of administrative procedures. This would save challenging parties the cost of initiating a judicial procedure and in most cases speed resolution of challenges. Timing is crucial in resolving patent challenges, since the patents are presumed valid until revoked.

 

Ir a la sección anterior
Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019